Tenax Therapeutics, Inc. TENX
Set alert
1.84 USD +0.04 +2.17%
As of Nov 3, 12:15 PM ET
1.79 Day range 1.92
1.31 52-week range 19.40
- YTD
- -84.91%
- 1 year
- -74.35%
- Open
- 1.81
- Prev close
- 1.80
- Mkt cap
- 68.86M
- Vol
- 1.58M
- Avg vol
- 5.66M
- EPS
- -1.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.79
- High
- 1.92
- Forward P/E
- -1.06
- Beta
- 2.15
- Short ratio
- 1.46
- Inst. own
- 47.95%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 1, 2024
- 50-d avg
- 4.96
- 200-d avg
- 3.94
- 1y target
- 16.30
5D chart
Signals (61)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 12:00 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 12:00 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 11:55 AM | 1 day ago |
| SMA: Bullish | Nov 2, 11:30 AM | 1 day ago |
| SMA: Bullish | Nov 2, 11:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 11:05 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:50 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:40 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:35 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 10:20 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:15 AM | 1 day ago |
| RSI: Overbought | Nov 2, 9:55 AM | 1 day ago |
| RSI: Overbought | Oct 30, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:05 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 11:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 4 days ago |
| RSI: Oversold | Oct 30, 9:45 AM | 4 days ago |
Newest 20 of 61.
Analyst view
Price target (mean) 16.30 +786.3% upside
Now 1.84
- Target (low)
- 7.00
- Target (mean)
- 16.30
- Target (high)
- 30.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.4225 | -1.23 – -0.14 | -8.64 | +95.1% | 0 | 0.0% | 4 |
| Next quarter | -0.175 | -0.18 – -0.17 | -3.12 | +94.4% | 0 | 0.0% | 2 |
| Current year | -2.28 | -6.24 – -0.60 | -31.04 | +92.7% | 0 | 0.0% | 4 |
| Next year | -1.05 | -1.68 – -0.76 | -2.28 | +53.9% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 24, 2024 | Leerink Partners | Initiated | — | Outperform |
| Feb 20, 2024 | Roth MKM | Reiterated | Buy | Buy |